SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Biocryst Pharmaceuticals's Partner Shionogi & Co., Ltd. Receives Approval for Pediatric Use Of Flu Drug Peramivir in Japan